Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
ABO, accomplish, acknowledged, adhere, adjuvant, AEROLIZER, age, AJCA, Allegra, AMT, analgesic, antibody, APB, API, Aquaculture, AQUAFLOR, aspect, Assistant, attention, attractive, Auditor, awaiting, backlog, behave, biennial, biological, body, bovine, bronchospasm, buprenorphine, cattle, center, CFC, CIGNA, clarify, CMS, COCCIVAC, Colligan, Companion, complicated, compulsory, conflicting, constant, constantly, contributor, costly, daily, denial, depth, description, Device, devoted, diagnosed, disability, disabled, dissolved, divert, dosing, doubling, DPI, driven, dry, dual, ear, elderly, encounter, enrollment, ERISA, Euro, evolving, excellence, experimental, explained, EXSPOT, eye, Factorsof, faster, fexofenadine, fish, FIT, Flonase, flu, fluctuation, fluoroquinolone, fluticasone, Footcare, foregoing, foreseeable, functional, GBM, glioblastoma, glioma, golimumab, GP, HCV, HFA, HIV, HOMEAGAIN, Hong, IIb, IIIa, implied, IMS, inability, inclusion, indirectly, Indonesia, infarction, ingestion, insecticide, insole, inspection, instrument, intermediary, interpartnership, intervention, invoice, invoiced, Japanese, Johnson, joined, Kidder, Kong, laboratory, lack, Latin, lice, Livestock, lose, lost, lotion, male, malignant, melanoma, MEMORY, met, metabolic, methodology, modified, monoclonal, multiforme, myocardial, naloxone, NE, newly, North, NOXAFIL, ophthalmic, packaged, packaging, PARACOX, parasiticide, partly, peer, pet, phosphodiesterase, PhRMA, plaque, PMDA, pneumonia, postpone, poultry, Pravachol, precisely, preclinical, preclusion, prevalence, prevalent, priority, Proceedingsin, progression, prohibitive, propionate, prosecute, protease, purpose, quoted, radiotherapy, rapidly, ratably, Ratify, rebalanced, recur, reevaluated, remeasured, Renahan, render, reputation, restructured, restructuring, Retroactive, rigor, salmon, Salnoske, sea, Senate, size, skin, SLICE, sneaker, staffing, streamline, strict, stringent, stronger, sunburn, swine, symposia, Taiwan, talent, tanning, temporary, thinly, Thrombin, today, toItem, tract, transition, Turnaround, twelve, TWISTHALER, UK, unavailable, undergoing, undertook, underway, uniform, urinary, VANCENASE, VANCERIL, veterinary, vicriviroc, waiting, wake, warehousing, Watson, weight, weighted, western, Wolf, workload
Removed:
accurate, affecting, affirmed, alia, amerisourcebergen, analyze, andSingulair, appeal, arisen, attained, attendant, broker, capture, claimed, conspired, coordination, copy, Corrupt, Daniel, declaratory, defraud, demanding, denied, desloratadine, discontinued, distributing, division, document, economically, enforcement, ensure, erosion, evaluate, extensive, FD, Florida, formed, formulary, fraudulently, GAAP, governing, grand, idiopathic, inflated, Influenced, insured, inter, investigate, jury, justified, lawsuit, liable, light, litigate, mg, motion, nationwide, nominally, nonprofit, overseeing, PAL, Panel, perception, perennial, plaintiff, precluded, preliminary, presence, priced, problem, promulgated, proper, punitive, purported, pursue, Racketeer, recommendation, refused, remedial, remover, reserving, reside, ruled, satisfactorily, shorter, Southern, sponsored, switched, taxation, tenor, thereunder, uncertified, underpaid, undertaken, urticaria, validated
Filing tables
Filing exhibits
- 10-K Annual report
- 10 EX-10.E.XII: Savings Advantage Plan
- 10 EX-10.L: Retirement Benefits Equalization Plan
- 12 EX-12: Computation of Ratio of Earnings to Fixed Charges
- 21 EX-21: Subsidiaries of the Registrant
- 23.1 EX-23.1: Consent of Deloitte & Touche LLP
- 23.2 EX-23.2: Independent Auditor's Consent
- 24 EX-24: Power of Attorney
- 31.1 EX-31.1: Certification
- 31.2 EX-31.2: Certification
- 32.1 EX-32.1: Certification
- 32.2 EX-32.2: Certification
Related press release
MRK similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 2-83963, No. 33-50606, No. 333-30331, No. 333-87077, No. 333-91440, No. 333-104714, No. 333-105567, No. 333-105568, No. 333-112421 and No. 333-121089 on Form S-8, Post Effective Amendment No. 1 to Registration Statement No. 2-84723 on Form S-8, Post Effective Amendment No. 1 to Registration Statement No. 333-105567 on Form S-8 and Registration Statements No. 333-12909, No. 333-30355 and No. 333-113222 on Form S-3, of our reports dated February 28, 2006, relating to the consolidated financial statements and financial statement schedule of Schering-Plough Corporation and management’s report of the effectiveness of internal control over financial reporting, appearing in this Annual Report on Form 10-K of Schering-Plough Corporation for the year ended December 31, 2005.
/s/Deloitte & Touche LLP
Parsippany, New Jersey
February 28, 2006